These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 25482652)
1. Reply: To PMID 24415445. Seo YS; Jung CH; Kim TH; Yim SY; Um SH Hepatology; 2015 Aug; 62(2):653-4. PubMed ID: 25482652 [No Abstract] [Full Text] [Related]
2. Lack of difference among vasoconstrictors: Similar effectiveness or similar ineffectiveness? Lo GH Hepatology; 2015 Aug; 62(2):653. PubMed ID: 25482959 [No Abstract] [Full Text] [Related]
3. Combination of splanchnic vasoconstrictors and endoscopic band ligation is an effective treatment strategy for acute variceal hemorrhage; but how do we get those drugs approved by the FDA? Fortune BE; Groszmann RJ Hepatology; 2014 Sep; 60(3):789-91. PubMed ID: 24700393 [No Abstract] [Full Text] [Related]
4. Terlipressin vs. octreotide in bleeding esophageal varices. Krag A; Bendtsen F Am J Gastroenterol; 2009 Sep; 104(9):2351; author reply 2351-2. PubMed ID: 19727090 [No Abstract] [Full Text] [Related]
6. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Seo YS; Park SY; Kim MY; Kim JH; Park JY; Yim HJ; Jang BK; Kim HS; Hahn T; Kim BI; Heo J; An H; Tak WY; Baik SK; Han KH; Hwang JS; Park SH; Cho M; Um SH Hepatology; 2014 Sep; 60(3):954-63. PubMed ID: 24415445 [TBL] [Abstract][Full Text] [Related]
7. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices. de Franchis R Dig Liver Dis; 2004 Feb; 36 Suppl 1():S93-100. PubMed ID: 15077917 [TBL] [Abstract][Full Text] [Related]
12. [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs]. Pulanić R Lijec Vjesn; 2000; 122(11-12):276-83. PubMed ID: 11291271 [TBL] [Abstract][Full Text] [Related]
14. Medical management of bleeding esophageal varices. Burroughs AK Dig Dis; 1992; 10 Suppl 1():30-7. PubMed ID: 1362377 [TBL] [Abstract][Full Text] [Related]
15. Hemodynamic effects of terlipressin in patients with bleeding esophageal varices secondary to cirrhosis of liver. Zuberi BF J Coll Physicians Surg Pak; 2007 Jun; 17(6):385; author reply 385-6. PubMed ID: 17623601 [No Abstract] [Full Text] [Related]
16. Best evidence topic report. Terlipressin or somatostatin for the treatment of bleeding oesophageal varices. Boyd R; Butler J Emerg Med J; 2005 Jun; 22(6):433-4. PubMed ID: 15911952 [TBL] [Abstract][Full Text] [Related]
17. Management of acute variceal bleeding. Lata J; Hulek P; Vanasek T Dig Dis; 2003; 21(1):6-15. PubMed ID: 12837994 [TBL] [Abstract][Full Text] [Related]
18. Approach to the management of bleeding esophageal varices: role of somatostatin. Avgerinos A Digestion; 1998; 59 Suppl 1():1-22. PubMed ID: 9603441 [TBL] [Abstract][Full Text] [Related]
19. Terlipressin: an asset for hepatologists! Sarin SK; Sharma P Hepatology; 2011 Aug; 54(2):724-8. PubMed ID: 21735463 [No Abstract] [Full Text] [Related]
20. Cirrhotic patients with large esophageal varices and older age have poor hemodynamic response to terlipressin. Kumar A; Sharma P; Mittal VV; Gupta N; Sarin SK Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):981-3. PubMed ID: 26114909 [No Abstract] [Full Text] [Related] [Next] [New Search]